Topics: Business enterprise, General

Encouraging performance in the first nine months

Encouraging performance in the first nine months

Chr. Hansen realizes strong organic growth of 9% in the first nine months of 2014/15, narrows organic revenue expectations to 8-9% and declares interim dividend to shareholders.

Overallokeringsret udnyttet fuldt ud

MÅ IKKE OFFENTLIGGØRES ELLER UDLEVERES HELT ELLER DELVIST, DIREKTE ELLER
INDIREKTE, I ELLER TIL USA, AUSTRALIEN, CANADA, JAPAN ELLER SYDAFRIKA.
Overallokeringsret udnyttet fuldt ud 
Samlet størrelse på børsnotering og udbud af aktier forøget til DKK 5.521 mio. 
Chr. Hansen Holding A/S (“Chr. Hansen”) offentliggør hermed, at Joint Global
Coordinators, Credit Suisse og J.P. Morgan (p

Finanskalender for regnskabsåret 2009/2010

Selskabsmeddelelse nr.4/20103. juni 2010

Finanskalender for regnskabsåret 2009/2010 

Delårsregnskab for de første 3 kvartaler 2009/2010: 1. juli 2010 

Årsrapport for 2009/2010: 2. november 2010 

Ordinær generalforsamling: 30. november 2010

Chr. Hansen fastsætter udbudskurs til DKK 90 pr. aktie i forbindelse med selskabets børsnotering og udbud af aktier

selskabsmeddelelse nr.3/20103, juni 2010

MÅ IKKE OFFENTLIGGØRES ELLER UDLEVERES HELT ELLER DELVIST, DIREKTE ELLER
INDIREKTE, I ELLER TIL USA, AUSTRALIEN, CANADA, JAPAN ELLER SYDAFRIKA 

Chr. Hansen fastsætter udbudskurs til DKK 90 pr. aktie i forbindelse med
selskabets børsnotering og udbud af aktier 

Chr. Hansen Holding A/S (“Chr. Hansen”, eller “Selskabet”), der er en g

About us

Chr. Hansen is a global, differentiated bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. At Chr. Hansen we are uniquely positioned to drive positive change through microbial solutions. We have worked for over 150 years to enable sustainable agriculture, better food and healthier living for more people around the world. Our microbial and fermentation technology platforms, including our broad and relevant collection of around 50,000 microbial strains, have game-changing potential. Matching customer needs and global trends we continue to unlock the power of good bacteria to respond to global challenges such as food waste, global health and the overuse of antibiotics and pesticides. As one of the world’s most sustainable companies, we touch the lives of more than 1 billion people every day. Driven by our legacy of innovation and curiosity to pioneer science, our purpose – To grow a better world. Naturally. – is at the heart of everything we do.

Chr. Hansen Holding A/S

Boege Allé 10-12
DK-2970 Hoersholm
Denmark

Chr. Hansen website
Investor Relations
Read more about Chr. Hansen
Enter your email address to follow Chr. Hansen Holding A/S

When you choose to create a user account and follow a newsroom your personal data will be used by us and the owner of the newsroom, for you to receive news and updates according to your subscription settings.

To learn more about this, please read our Privacy Policy, which applies to our use of your personal data, and our Privacy Policy for Contacts, which applies to the use of your personal data by the owner of the newsroom you follow.

Please note that our Terms of Use apply to all use of our services.

You can withdraw your consent at any time by unsubscribing or deleting your account.
Check your inbox

Email sent to __email__. Click the link there to follow Chr. Hansen Holding A/S.

Okay